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Background: Acute mastoiditis (AM) is a suppurative infection of the mastoid air cells, representing the
most frequent complication of acute otitis media. AM remains an important entity in children due to its
potential complications and sequelae. We aim to describe the cases of AM admitted at our department,
identify risk factors potentially associated with complications and analyse the changes in clinical
approach of AM over time.
Methods: Case review of clinical ﬁles of children admitted with acute mastoiditis from June 1996 to May
2013 at a Lisbon metropolitan area hospital. Data was divided into two groups (prior and after May 2005)
in order to evaluate changes in AM approach over the years.
Results: 135 AM episodes were included. The median age was 3.8 years and 42% children were less than
24 months of age. Symptoms at presentation included fever (69%), ear pain (56%) and otorrhea (40%).
Complications occurred in 22% patients and were more common in children under 24 months (33% vs
15%, p  0.01).
Leukocyte count was signiﬁcantly higher in children with complications (16.7 vs 14.5  109/mL, p  0.05)
as was C-Reactive Protein value (13 vs 6.3 mg/dL, p  0.001). There was a signiﬁcant association between
the development of complications and C-Reactive Protein value at admission (OR 1.892; IC95%: 1.018
e2.493, p  0.01). The optimal cut-off value was 7.21 mg/dL.
Over time there was a signiﬁcant increase in middle ear cultures obtained by tympanocentesis during
surgery (2% vs 16%, p  0,01) and also a decrease in the use of broad spectrum antibiotherapy as initial
treatment (52% vs 25%,p  0,001).
Conclusions: Children under 24 months, with high leukocyte count or with high C-Reactive Protein value
should be monitored closely since complications tend to be more frequent. A CRP value of 7.21 mg/dL at
admission seems to be a good cut-off to monitor children for potential complications.
Throughout the period analysed more cultures were performed allowing identiﬁcation of the pathogens
and implementation of appropriate antibiotic therapy.
© 2016 Elsevier Ireland Ltd. All rights reserved.Contents
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Acute mastoiditis is a suppurative infection of mastoid air cells
with symptoms lasting less than one month. It is the main
complication of acute otitis media (AOM) affecting 1 in 400 cases
(0,24%) [1].
The middle ear is connected to the mastoid by the aditus ad
antrum. Therefore, most episodes of AOM are associated with
inﬂammation of the mastoid mucosa [2,3].
When the inﬂammatory process persists, obstruction of the
aditus ad antrum occurs and purulent material accumulates within
the mastoid cavities evolving to acute mastoiditis [2,4,5]. If infec-
tion extends to the periosteum underlying the mastoid process,
periosteitis may develop. As the pressure increases, destruction of
the bone matrix occurs causing acute mastoiditis with osteitis [4].
Once cortical destruction develops, the infection may progress to
adjacent structures.
Signs and symptoms may include fever, ear pain, post-auricular
tenderness and pinna protrusion [2,6]. The most commonly
involved pathogen is Streptococcus pneumoniae although Haemo-
philus inﬂuenzae, Streptococcus pyogenes, Staphylococcus aureus and
Pseudomonas aeruginosa may also be involved [4,6,7].
Acute mastoiditis is more common in boys and has a peak
incidence between the second and third years of life, similar to that
of AOM. This peak is associated not only with the physiological
immaturity of the immune system but also with the small size of
the aditus ad antrum in this age group, favoring its obstruction
during the inﬂammatory process of otitis [4,6]. The proximity of the
mastoid to the facial nerve, jugular vein, internal carotid artery,
sigmoid sinus, meninges and brain is crucial to the development of
complications [2,4].
Acute mastoiditis has once been amajor cause of hospitalization
in children, decreasing dramatically since the introduction of an-
tibiotics [2]. Authors disagree onwhether its incidence is increasing
in the last years [2,7e14]. Since acute mastoiditis remains an
important entity in pediatrics, knowledge of its pathophysiology in
each institution remains of extreme importance.
In this report, we aim to describe the cases of acute mastoiditis
admitted at our department of pediatrics and identify risk factors
potentially associated with complications. We also intend to anal-
yse the changes in the clinical approach of acute mastoiditis over
the years at our department regarding diagnostic exams, treatment,
complications and follow-up.2. Material and methods
Case review of clinical ﬁles of children admitted to the depart-
ment of pediatrics with acute mastoiditis in the period from June
1996 to May 2013 (seventeen years).
Acute Otitis Mediawas deﬁned based on the American Academy
of Pediatrics (AAP) guidelines as the presence of moderate to severe
bulging of tympanic membrane, new onset of otorrhea not due to
otitis externa or as the presence of mild bulging of the tympanic
membrane associated with a less than 48 h onset of ear pain orintense erythema of the tympanic membrane [15].
Inclusion criteria were the coexistence of AOM and one or more
clinical signs suggestive of acute mastoiditis: peri-auricular
inﬂammation signs such as erythema, blush or edema, loss of
retro-auricular crease or displacement of the pinna. All children
were evaluated by an otolaryngology expert at admission.
Cases of acute mastoiditis diagnosed by image exams without
clinical symptoms were excluded.
The children's medical history was reviewed focusing on the
previous episodes of AOM. Recurrent AOM was deﬁned according
to AAP guidelines as either three AOM episodes in six months
period or four or more episodes in one year [15]. Personal back-
ground of otorhinolaryngologic disease was deﬁned as the pres-
ence of one or more of the following: recurrent AOM, adenoidal
hypertrophy, sinusitis or previous episode of acute mastoiditis.
Complications of acute mastoiditis were divided into intracra-
nial (meningitis, venous thrombosis and cerebral abscess) and
extracranial (facial paralysis, subperiosteal abscess, abscess of
Bezold and labyrinthitis). It was considered a risk factor for
complicated acute mastoiditis if the child was under twenty-four
months, had a background of otorhinolaryngologic disease, had
an episode of AOM treated with antibiotics in the three months
prior to admission and also if the child was under antibiotic therapy
for AOM. Leukocytosis was deﬁned as total leukocyte count equal to
or greater than two standard deviations for age and sex.
Broad spectrum antibiotics were deﬁned as the ones effective
against a wide range of infectious microorganisms including both
gram positive and gram negative bacteria such as ceftriaxone and
cefuroxime.
Changes in clinical practice regarding the approach of acute
mastoiditis were analysed based on the previously published report
by Salgueiro B et al. [7]. This was a retrospective case series un-
dertaken at the same department of pediatrics that included all
acute mastoiditis admissions from June 1996 through May 2005. A
clinical protocol was implemented after data analysis in 2005. The
protocol deﬁned the diagnostic criteria for acute mastoiditis, as
well as a structured approach for the child with suspect AM con-
cerning the need for diagnostic exams and the empirical antibiotic
therapy instituted.
In this report we considered two distinct time periods: before
and after the protocol implementation. Patients were divided into
two distinct groups: group A (admission from June 1996 through
May 2005) and group B (admission from June 2005 through May
2013).
Statistical analysis was performed using SPSS® 21.0 (SPSS, INC.,
Chicago, USA). For numerical variables with normal distribution,
the mean and standard deviation were calculated. The median,
minimum and maximum values were calculated for non-normal
distribution variables. The comparative analysis was performed
using a chi-square test for categorical variables. For continuous
variables with normal distribution the student t-test was per-
formed and for continuous variables with non-normal distribution
the Mann-Whitney test.
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3.1. Epidemiology
In the period analysed there were 135 acute mastoiditis epi-
sodes that met the inclusion criteria. Most patients were boys (60%)
and caucasian (90%). The median age was 3.8 years (range 4.7
monthse16.3 years). 57 children (42%) were less than 24months of
age and 17% less than 12 months. Only 16% were more than ten
years old.
The highest number of admissions (15%) was in 2006. Most
cases occurred during summer (31%), particularly in August (15%).
The year distribution is represented in Fig. 1. History of previous
otorhinolaryngologic disease was documented in 53 children
(39%): recurrent AOM (36%), adenoidal hypertrophy (10%), previous
episode of acute mastoiditis (10%) and sinusitis (3%).
3.2. Clinical ﬁndings and diagnostic exams
All children had AOM at admission. Signs and symptoms at
presentation included fever (69%), ear pain (56%) as well as otor-
rhea (40%). Two patients presented with peripheral facial paralysis.
One child was in septic shock at admission. The median length of
time between the beginning of symptoms and hospital admission
was three days (range 1e14 days).
Analysis with complete blood count and C-Reactive Protein
(CRP) were performed in every patient. The majority (72%) had
leukocytosis, with a mean value of 15.1 ± 5.4  109/mL. Mean CRP
value was 5.4 mg/dL (range 0.2e43 mg/dL).
In 45 children (33%) cultures were obtained from either the ear
canal (31), middle ear (13) or abscess drainage (one). In 26 cultures
(58%) bacterial growth was documented. Of the cultures obtained
from ear canal swab,18 (58%) isolated Pseudomonas aeruginosa (one
of which also isolated Staphylococcus aureus), four Streptococcus
pneumoniae and in one grew an unidentiﬁable gram-negative
bacilli. Cultures from the middle ear were obtained by tympano-
centesis during surgery with Streptococcus pneumoniae being iso-
lated in two (15%). Streptococcus pyogenes was isolated in the
culture of purulent material obtained during a retro-auricular ab-
scess drainage. Cultures contamination rate was 11%.
Computed Tomography Scan (CT-Scan) was performed in 89%0 0 0
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Fig. 1. Year distribution of acute mastoiditis admissions and complications (either intracrani
only ﬁve months).children, mainly (87%) either at admission or during the ﬁrst day of
hospitalization. In two children (1.5%) Magnetic Resonance Image
(MRI) was also performed due to suspicion of intracranial compli-
cations after CT-Scan.
3.3. Antibiotic therapy and surgery
In the three months prior to admission, 71 children (53%) had
been under antibiotics, 91% to treat acute otitis media. At admission
45 children (33%) were under antibiotherapy for AOM. There was
no information available about the duration of treatment prior to
admission.
All children started empiric intravenous antibiotic therapy. 131
(90%) were started on monotherapy with either amoxicillin/clav-
ulanic acid (47%), ceftriaxone (36%) or cefuroxime (6%). The
remaining 14 patients were treated with combined antibiotherapy
due to concomitant external otitis (5%) or presence of
complications.
During hospitalization antibiotic therapy was adjusted in 18
(13%) patients: in nine switched to broad spectrum antibiotics (six
cases with complications detected on CT-Scan and three cases
without clinical improvement after 72 h of therapy); in two chil-
dren adjusted to a narrower spectrum antibiotic after CT-Scan
images showed no evidence of complications that were initially
suspected. In seven children therapeutic adjustment was made
after culture results.
31 (23%) children underwent surgery, mostly (65%) in the ﬁrst
two days after admission. 29 children underwent myringotomy
with insertion of ventilation tubes, six children underwent
drainage of post-auricular abscess and six children underwent
mastoidectomy. All patients submitted to mastoidectomy had
osteitis and two of them also had post-auricular abscesses that
were drained during the surgical procedure.
3.4. Complications
Complications occurred in 30 children (22%). Fig. 1 documents
the evolution of complications throughout the years. CT-Scan was
performed in all of them. 19% of complications were extracranial:
post-auricular abscess (10%), post-auricular phlegmon (6%), Bezold
abscess (2%), facial paralysis (2%) and occipital osteomyelitis with0
2
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4
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al or extracranial) over the years (in 1996 only seven months were analysed and in 2013
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occurred in three children (2%): one had a subperiosteal abscess,
one had internal jugular vein thrombosis and one eight-month boy
had lateral sinus thrombosis, cerebritis and a temporal lobe cere-
bral abscess. The latter presented in septic shock and died eighteen
days after admission. The mortality rate was 0,7%.
Children under twenty-four months had signiﬁcantly more
complications than older patients (33% vs 15%, p ¼ 0.006). As far as
laboratory ﬁndings are concerned: leukocyte count was signiﬁ-
cantly higher in childrenwith complications (16.7 ± 6.1  109/mL vs
14.5 ± 5.1 109/mL, p¼ 0.046) as was CRP value (13 ± 10.9 mg/dL vs
6.3 ± 6 mg/dL, p ¼ 0.001). Table 1 illustrates the comparison be-
tween children with and without complications.
A logistic regression model performed with variables associated
with complications revealed a signiﬁcant association with CRP
value (OR 1.892; IC95%: 1.018e2.493, p ¼ 0.01) -Table 2. The ac-
curacy obtained from the Receiver Operating Characteristic (ROC)
curve for CRP value was 0.703 (IC95% 0.585e0.821). The optimal
cut-off point for C-Reactive Proteinwas 7.21mg/dL (sensitivity 66%;
speciﬁcity 73%).
3.5. Follow-up
Eight children (6%) had more than one episode of acute
mastoiditis and one child had two relapses. In ﬁve cases (63%) the
second episode occurred less than a year after the ﬁrst one.
Most children (88%) had follow-up appointments by an otorhi-
nolaryngology expert after discharge and ﬁfty-eight (43%) also by a
pediatric infectious disease expert. Information about the length of
follow-up was not available.
3.6. Management of acute mastoiditis over the years
We compare two different time periods, before and after the
implementation of an acutemastoiditis protocol in our department.
In the period from June 1996 through May 2005 (group A) there
were 58 admissions comparing to 77 from June 2005 through May
2013 (group B).
In the former years (group B) an increased in diagnostic exams
was registered: ear exudate cultures (21% vs 43%, p ¼ 0.007) due to
the increase in middle ear cultures obtained by tympanocentesis
during surgery (2% vs 16%, p ¼ 0.005). There was also a signiﬁcant
increase in CT-Scans (76% vs 99%, p ¼ 0.001).
Regarding empiric antibiotic therapy at admission, in group B
signiﬁcantly more children were started on amoxicillin/clavulanic
acid (31% vs 57%, p¼ 0.003) whereas in group A a signiﬁcant higherTable 1
Analysis of acute mastoiditis complications.
Age  24 months
Previous otolaryngology diseases
(recurrent AOM, adenoidal hypertrophy, sinusitis and/or previous episodes of AM)
Antibiotics for AOM < 3months prior to admission
Antibiotics at admission
Leukocyte count
C-Reactive Protein (CPR)
Surgery
Recurrences
Legend: AOM: acute otitis media; AM: acute mastoiditis; þp > 0,05; *0,05  p  0,01; **number of children was medicated either with ceftriaxone (52% vs
25%, p¼ 0.001) or cefuroxime (10% vs 1%, p¼ 0.02). Group B tend to
have more complications (19% vs 25%, p ¼ 0.43) and more children
were submitted to surgery (17% vs 28%, p ¼ 0.19) albeit not a sig-
niﬁcant number. Hospitalization length was signiﬁcantly higher in
group B (7.8 ± 4.1 vs 10.4 ± 8 days, p ¼ 0.01).
There were more children with follow-up consultations in the
latest years, both by an otorhinolaryngology expert (79% vs 97%,
p ¼ 0.001) and infectious diseases expert (12% vs 67%, p ¼ 0.001).
Table 3 illustrates the differences between the two groups.
4. Discussion
There is no consensus on the variation of acute mastoiditis
incidence in the last years [9,11e14,16]. Most reports are not pop-
ulation based and more importantly, antibiotic prescription politics
for children diagnosed with AOM differ in several countries, which
may contribute to data differences. In our analysis the distribution
was irregular over time, although there was a peak in 2006 and a
higher percentage of cases occurred after 2005- Fig. 1.
Of the total, 42% children were under 24 months and this group
had signiﬁcantly more complications that older children
(p ¼ 0.006), similar to what's described by other data [1,5,12,17,18].
This reﬂects the anatomic and immunologic particular features of
this age group which predisposes them not only to the disease but
also to its complications [4,6].
Leukocyte count was signiﬁcantly higher in children with
complications (16.7  109/mL vs 14.5  109/mL, p ¼ 0.046) as was C
Reactive Protein value (13 mg/dL vs 6.3 mg/dL, p ¼ 0.001), as also
reported previously [4]. A CRP value higher than 7.21 mg/dL at
admission was associated with 1.9 times more risk of complica-
tions. The accuracy of the logistic regression was 0.703 which is a
fair value specially when we are concerning possible distinct
medical approaches upon a laboratory cut-off value. When evalu-
ating children at admission, the pediatrician becomes aware that
more than two-thirds (66% sensitivity) of childrenwith a CRP value
higher that 7.21 mg/dL will have complications and hence require a
different vigilance than if this value is lower than 7.21 mg/dL when
the vast majority (73% speciﬁcity) will not have a complicated
mastoiditis episode. Although more studies are needed to conﬁrm
this data, establishing a cut-off value is of utmost importance since
it identiﬁes at admission children with higher potential for com-
plications and allows a tighter surveillance.
Ear exudate cultures were performed in only 33% of cases, a very
modest number when compared to other reports [13,18,19].
Although 33 children underwent surgery, only 39% middle-earComplications
Yes (n ¼ 30) No (n ¼ 105)
P
Yes
No
19
11
38
67
**
Yes
No
9
21
44
61
þ
Yes
No
17
13
54
51
þ
Yes
No
16
14
52
53
þ
Mean (109mL) 16.7 ± 6.1 14.5 ± 5.1 *
Mean (mg/dL) 13 ± 10.9 6,3 ± 6 **
Yes
No
17
12
14
92
**
Yes
No
1
29
8
96
þ
0,01  p  0,001.
Table 2
Analysis of potential risk factors for developing complications (logistic regression).
IC 95%
OR Lower Upper p value
Age  24 months 0,472 0156 1431 0,185
Previous otolaryngology diseases* 1059 0,365 3074 0,916
Antibiotics for AOM <3months prior to admission 0,547 0034 8676 0,669
Antibiotics at admission 1209 0,083 21,167 0,840
Leukocyte count 1041 0,948 1143 0,403
C-Reactive Protein (CPR) 1892 1018 2493 0,010*
Legend: AOM: acute otitis media; * deﬁned as recurrent AOM, adenoidal hypertrophy, sinusitis and/or previous episodes of acute mastoiditis.
Table 3
Clinical management of acute mastoiditis over time.
Group A (n ¼ 58) Group B (n ¼ 77) p
Ear cultures 21% 43% **
Ear canal 19% 26% þ
Middle Ear 2% 16% **
Abscess drainage e 1.3% þ
CT-Scan 76% 99% **
Inicial antibiotherapy
Monotherapy 93% 83% þ
Amoxicilin/clavulanic acid 31% 57% **
Ceftriaxone 52% 25% **
Cefuroxime 10% 1.3% *
Combined antibiotherapy 7% 17% þ
Surgery 17% 28% þ
Complications 19% 25% þ
Hospitalization length (mean/days) 7.8 ± 4,1 10.4 ± 8 *
Recurrences 5% 9% þ
Follow-up consults
Otolaryngology 79% 97% **
Infectious Diseases 12% 67% **
Legend: Group A: admissions from June 1996 through May 2005; Group B: ad-
missions from June 2005 through May 2013. þ p > 0,05; * 0,05  p  0,01; **
0,01  p  0,001.
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collected from the ear canal, one of which also isolated Staphylo-
coccus aureus. These pathogens are part of the ear canal saprophyte
ﬂora and therefore considered contamination, or simultaneous
infection, of the ear canal by some authors [12]. Some reports
considered that even when isolated, Pseudomonas aeruginosa and
Staphylococcus aureus are not the main causative agents of acute
mastoiditis and so antibiotic treatment should not be modiﬁed
unless the clinical course is complicated [12,19]. In our study, only
two (15%) cultures collected from the middle ear during surgery
were positive, both for Streptococcus pneumoniae. If we consider
Pseudomonas aeruginosa as a local ﬂora agent, Streptococcus pneu-
moniae was the most common pathogen, as also documented in
other series [1,2,13,17].
Most authors agree that the diagnosis of acute mastoiditis is
clinical. It is still controversial when CT-Scans should be performed.
It is consensual that image exams should be performed in case of a
prolonged or complicated course of disease or when clinical signs
suggest complications [2,12]. Some reports state that in most pe-
diatric patients there is no evidence supporting that CT-Scan alters
patient outcome [4,14,20]. However, other authors suggest that
clinical examination is not able to identify all cases of complications
and therefore additional exams should be performed whenever the
patient is treated conservatively [21]. In our department, CT-Scan
was widely used, especially in the last years (after May 2005 all
but one child was submitted to this exam)- Table 3. To our
knowledge, CT-Scanwas important to characterize the extent of the
disease and to exclude complications, allowing the institution of
appropriate therapy right at admission, since 87% of exams wereperformed in the ﬁrst 48 h of hospitalization. It is possible that by
performing CT-Scans almost as a routine may have led in some
cases to treatment of image ﬁndings instead of treating children
based only on clinical signs. Nonetheless this approach allows early
detection of complications before they are clinically evident.
Evaluating the approach to acute mastoiditis in our department
over the years, some conclusions can be drawn. In latter years,
signiﬁcantly more ear effusion cultures were performed
(p ¼ 0.007), especially more middle ear cultures. This reveals the
growing concern in identifying the pathogen responsible for the
disease. Thus an appropriate directed antibiotherapy can be
implemented therefore avoiding broad-spectrum antibiotics and
potential future resistances.
A major limitation of this study is its retrospective design. As a
prolonged period of time was analysed, it was difﬁcult to collect
data from the initial study period. However we believe that
including all acute mastoiditis admissions of our department is an
asset and allows the evaluation of the disease management over
the years.
5. Conclusion
The possibility of severe complications and consequent future
sequelae determine that acute mastoiditis remains an important
entity in pediatrics. Children under 24 months of age presenting
with important leukocytosis or high C-Reactive Protein value at
admission should be monitored closely since complications tend to
be more frequent.
In our department there has been an effort over to years to
identify the pathogens responsible for the disease as well as
changing antibiotic politics to avoid potential resistances.
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